LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.22 | 771.67 | 1509 | 4299 | 0.3510 | 0.3108 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.44 | 771.67 | 1621 | 4738 | 0.3421 | 0.3277 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.44 | 771.67 | 1558 | 4738 | 0.3288 | 0.3078 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 42.67 | 771.67 | 1665 | 5155 | 0.3229 | 0.3240 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 42.67 | 771.67 | 1617 | 5155 | 0.3136 | 0.3099 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 44.89 | 771.67 | 1721 | 5541 | 0.3106 | 0.3258 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 44.89 | 771.67 | 1658 | 5541 | 0.2992 | 0.3085 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 47.11 | 771.67 | 1744 | 5941 | 0.2935 | 0.3190 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 47.11 | 771.67 | 1699 | 5941 | 0.2860 | 0.3074 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 49.33 | 771.67 | 1828 | 6392 | 0.2860 | 0.3268 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 49.33 | 771.67 | 1764 | 6392 | 0.2759 | 0.3113 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 51.55 | 771.67 | 1902 | 6829 | 0.2785 | 0.3321 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 51.55 | 771.67 | 1792 | 6829 | 0.2624 | 0.3071 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.77 | 771.67 | 1936 | 7256 | 0.2668 | 0.3291 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.77 | 771.67 | 1799 | 7256 | 0.2479 | 0.2993 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.99 | 771.67 | 2102 | 7690 | 0.2733 | 0.3527 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.99 | 771.67 | 1986 | 7690 | 0.2583 | 0.3298 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.21 | 771.67 | 2118 | 8085 | 0.2620 | 0.3470 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.21 | 771.67 | 2014 | 8085 | 0.2491 | 0.3272 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 60.44 | 771.67 | 2208 | 8530 | 0.2588 | 0.3543 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 60.44 | 771.67 | 2008 | 8530 | 0.2354 | 0.3177 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 62.66 | 771.67 | 2281 | 8978 | 0.2541 | 0.3582 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 62.66 | 771.67 | 2138 | 8978 | 0.2381 | 0.3335 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 64.88 | 771.67 | 2309 | 9447 | 0.2444 | 0.3543 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 64.88 | 771.67 | 2197 | 9447 | 0.2326 | 0.3358 | MN20160304_L01 | N22 |